丙肝

专题首页 » 丙肝

⇔ [APASL2014]SOF+RBV in HIV/HCV Co-infected Patients 2014-03-25
⇔ [APASL2014]Deep Sequencing of Hepatitis C Virus to Detect Drug Resistance Mutations 2014-03-19
⇔ [APASL2014]Making Noise: The Next Step in Addressing Viral Hepatitis 2014-03-15
⇔ [APASL2014]Second Gen DAAs Show Promise in the C-SPIRIT Trail 2014-03-14
⇔ [APASL2014]Barriers to Treating Liver Disease in the Asia-Pacific 2014-03-14
⇔ [APASL2014]The Lonestar Trial: SOF/LDV combination sufficient for SVR12 without RBV 2014-03-14
⇔ [APASL2014]Progress and Prospect of the Prevention and Control of Hepatitis——Interview with Mr.Charles Gore 2014-03-14
⇔ [APASL2014]Comment-Amanda Nicoll 2014-03-13
⇔ [APASL2014]State of Play:New Tools for Hepatologists 2014-03-12
⇔ [APASL2014]Debate:Does Interferon Still Have a Role in HCV Treatment? 2014-03-12
⇔ [APASL2014]Host genomics and HCV treatment response:IL-28 and beyond 2014-03-12
⇔ [APASL2014]The Changing Landscape of Transplantation for HCV 2014-03-12
⇔ [APASL2013]IFN–free Regimen: The Future Goal for Hepatitis C——interview with Dr.Edward Gane 2013-06-18
⇔ [APASL2013]The future of HCC in a Post-HCV World——interview with Prof. Masao Omata 2013-06-08
⇔ [APASL2013]N-CORE: Sustained Virological Response Rates with Peginterferon Alfa-2a/Ribavirin (PegIFN-alfa/RBV) in HCV G2 or 3 Patients without Rapid Virological Response 2013-06-07
⇔ [APASL2013]Could Vitamin D Supplementation Improve Response to Antiviral Treatment for Hepatitis C Virus Genotype 4? 2013-06-07
⇔ [APASL2013]Responses and Adverse Effects of Triple Therapy with Telaprevir， PegIFN and Ribavirin in Patients with Hepatitis C Virus Infection 2013-06-07
⇔ [APASL2013]A Novel Method for Non-Invasive Diagnosis of Hepatitis C Virus Using Electromagnetic Signal Detection: A Multicenter International Study 2013-06-07
⇔ [APASL2013]48 Weeks of Therapy Might Not Be Needed for the Patients with HCV Genotype 2 without RVR like EASL Guideline 2013-06-07
⇔ [APASL2013]All Oral Therapy with Sofosbuvir+Ribavirin for 12 or 16 Weeks in Treatment Experienced Genotype 2/3 HCV-Infected Patients: The FUSION Trial 2013-06-07

首页 1 2 下一页尾页

丙肝

专题标签

学术领域

扫描二维码，用手机看今日话题